Iron metabolism disorders are a broad family of conditions in which the body absorbs, stores, distributes, or recycles iron abnormally. Some cause dangerous iron overload, others starve tissues of iron even when dietary intake is adequate, and a handful trap iron in specific organs like the brain or inside mitochondria. What ties them together is a breakdown in the tightly regulated system that normally keeps circulating iron within a narrow, safe range. Because iron is both essential for oxygen transport and toxic when it accumulates unchecked, even modest disruptions in its handling can cause serious organ damage over time.
How the Body Keeps Iron in Balance
A healthy diet delivers roughly 5 to 15 milligrams of iron a day, but only about 1 to 2 milligrams actually gets absorbed, mostly in the upper part of the small intestine.1PubMed Central. Iron deficiency anaemia: pathophysiology, assessment, practical management Iron enters intestinal cells through a transporter that works best after the mineral has been chemically reduced on the cell surface.2PubMed. Intestinal iron absorption From there, the iron either stays parked inside those cells or is exported into the bloodstream through a channel protein called ferroportin, the only known exit route for cellular iron.
The master regulator of this export step is a small hormone called hepcidin, produced in the liver. When the body senses that iron levels are adequate or that inflammation is present, hepatocytes ramp up hepcidin production. Hepcidin binds directly to ferroportin, triggering the channel to be pulled inside the cell and broken down.3PubMed Central. Hepcidin and Iron in Health and Disease 4Biochimica et Biophysica Acta (BBA) – Molecular Cell Research. Hepcidin and iron homeostasis With ferroportin gone, iron stays trapped in gut-lining cells and in the macrophages that recycle old red blood cells, and less iron reaches the plasma. When iron stores drop or the bone marrow needs more iron to build red blood cells, hepcidin falls and ferroportin reappears, opening the gates.
Nearly every iron metabolism disorder can be traced to something going wrong with this hepcidin-ferroportin axis, whether the problem is too little hepcidin, too much, or a failure to respond to it properly.
Hereditary Iron Overload
The most common inherited iron disorder in people of European descent is hereditary hemochromatosis, overwhelmingly caused by a single mutation in the HFE gene. This mutation, known as C282Y, is carried by up to one in eight people in certain European populations.5PubMed Central. Pathophysiological consequences and benefits of HFE mutations: 20 years of research People who inherit two copies of the mutant gene produce inadequate hepcidin for the amount of iron in their body, so ferroportin stays active on gut cells and macrophages. The result is relentless iron absorption that slowly fills the liver, pancreas, heart, and joints. Symptoms typically creep in during middle age: fatigue, joint pain, elevated liver enzymes, and sometimes skin bronzing or diabetes. Left untreated, the liver can develop cirrhosis or cancer.
A rarer and more aggressive form, juvenile hemochromatosis, appears in adolescence or early adulthood and is linked to mutations in genes for hemojuvelin or hepcidin itself.6Gastroenterology. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes Because hepcidin production is even more severely impaired, iron accumulates faster, and heart failure or severe endocrine damage can develop before age 30 if the condition goes unrecognized.
Iron Deficiency That Isn’t About Diet
Iron deficiency anemia is often framed as a dietary problem, and sometimes it is. But a large category of iron deficiency has nothing to do with what you eat. In chronic inflammatory conditions, the body deliberately withholds iron from the bloodstream by driving up hepcidin. The inflammatory signaling molecule interleukin-6 is a particularly strong trigger for hepcidin production.7PubMed Central. Iron sequestration and anemia of inflammation With hepcidin high, ferroportin is dismantled across the body, iron gets trapped inside cells, and red blood cell production slows because the bone marrow cannot get enough iron to make hemoglobin. This is anemia of inflammation, sometimes called anemia of chronic disease, and it can appear alongside kidney disease, rheumatoid arthritis, infections, or cancer.
The frustrating clinical reality is that standard iron pills often do little for anemia of inflammation because the problem is not a lack of iron in the body but a lack of iron in the right compartment. The body has plenty of iron locked away in macrophages and liver stores. Giving more oral iron just adds to the stuck pool. Identifying the underlying inflammation and addressing it is generally more effective than iron supplementation alone.
An even more specific genetic version exists called iron-refractory iron deficiency anemia, where mutations cause hepcidin to be permanently elevated. These patients absorb almost no dietary iron and barely respond to oral supplements despite clear deficiency.
Transfusional Iron Overload
People who rely on regular red blood cell transfusions for conditions like beta-thalassemia major, myelodysplastic syndromes, or sickle cell disease face a different iron problem. Each unit of transfused blood delivers a large bolus of iron, and the human body has no active excretion pathway for iron. Over months and years, transfusion-dependent patients accumulate iron that damages the liver, the endocrine system, and the heart.8PubMed. How I treat transfusional iron overload Cardiac iron overload is the leading cause of death in undertreated thalassemia major.
Because these patients cannot simply stop transfusions, their iron burden must be managed with chelation therapy. Iron chelators are drugs that bind free iron in the body and allow it to be excreted in urine or stool. Phlebotomy, which works well for hereditary hemochromatosis, is generally not an option because these patients are already anemic.9Journal of Trace Elements in Medicine and Biology. Iron mobilization using chelation and phlebotomy
Why Excess Iron Is Toxic
Iron’s danger comes from its chemistry. Small amounts of unbound “free” iron in cells can catalyze a reaction that generates hydroxyl radicals, among the most damaging molecules the body encounters. These radicals attack DNA, proteins, and cell membranes indiscriminately.10PubMed. Labile iron pool: the main determinant of cellular response to oxidative stress In a healthy cell, the pool of free iron is kept vanishingly small by careful regulation of storage and transport proteins. When that regulation fails, free iron rises, and oxidative damage snowballs.
Researchers have identified a specific form of cell death driven by iron-catalyzed damage to membrane fats, called ferroptosis. Unlike the tidy, programmed cell death the body uses during normal tissue turnover, ferroptosis involves a breakdown of the cell’s lipid repair machinery and an accumulation of toxic lipid byproducts.11PubMed Central. Ferroptosis: Death by Lipid Peroxidation Ferroptosis has become a major area of interest in cancer biology, neurodegeneration, and organ injury research, because manipulating it might offer new treatment angles for conditions where iron-driven cell death contributes to tissue damage.
Iron Trapped in the Brain
A group of inherited neurological conditions collectively called neurodegeneration with brain iron accumulation, or NBIA, illustrate how devastating misplaced iron can be. In these disorders, iron gradually builds up in deep brain structures, particularly the basal ganglia, causing progressive movement problems, cognitive decline, and in some forms, vision loss.12PubMed Central. Neurodegeneration with brain iron accumulation The most common genetic form involves mutations in the PANK2 gene, which disrupts coenzyme A metabolism. Children with this form often present with involuntary posturing and abnormal eye movements, while adults develop speech difficulties and psychiatric symptoms.
Other NBIA subtypes involve mutations in different genes, including PLA2G6, which encodes a protein critical to cell membrane integrity.13PubMed. Neurodegeneration with brain iron accumulation: from genes to pathogenesis What these disorders share is that the brain’s local iron-handling machinery goes wrong, and iron accumulates where it should not. Conventional blood tests for iron may look completely normal because the problem is compartmentalized. Diagnosis usually requires brain MRI, which reveals a characteristic dark signal in the basal ganglia from iron deposits.14PubMed Central. Neurodegeneration with brain iron accumulation: diagnosis and management
A separate condition, aceruloplasminemia, causes brain iron accumulation through a different route. People who lack the protein ceruloplasmin cannot properly oxidize iron for export from neurons and other brain cells. Iron builds up inside those cells because it essentially cannot leave.15Brain Research Reviews. Rethinking the role of ceruloplasmin in brain iron metabolism Unlike the NBIA group, aceruloplasminemia also causes iron overload in the liver and retina, and patients often develop diabetes alongside their neurological decline.
When Mitochondria Hoard Iron
Congenital sideroblastic anemias are a distinct set of inherited blood disorders where iron piles up inside the mitochondria of developing red blood cells. Under a microscope, affected bone marrow cells show a telltale ring of iron granules encircling the nucleus, called ring sideroblasts.16PubMed. Mitochondrial iron metabolism and sideroblastic anemia The underlying genetic causes are varied but share a common thread: they disrupt either heme synthesis, the assembly of iron-sulfur clusters, or the protein-building machinery within mitochondria.17Hematology Am Soc Hematol Educ Program. Congenital Sideroblastic Anemias: Iron and Heme Lost in Mitochondrial Translation
Patients with sideroblastic anemias present with anemia because their red blood cells cannot properly incorporate iron into hemoglobin, even though the body has absorbed plenty of iron. Some forms respond to high-dose vitamin B6, which supports one of the enzymes in heme production. Others do not respond and require transfusions, which then compounds the problem by adding to overall iron overload.
The Erythroferrone Signal
For decades, researchers knew that after blood loss or during periods of intense red blood cell production, the body suppresses hepcidin to free up more iron. But the signal linking the bone marrow’s demand to the liver’s hepcidin output was only identified in 2014 with the discovery of a hormone called erythroferrone. Erythroferrone is produced by developing red blood cell precursors in response to erythropoietin, the hormone that ramps up red blood cell production. When erythroferrone reaches the liver, it suppresses hepcidin, increasing iron absorption and release from stores.18Nature Genetics. Identification of erythroferrone as an erythroid regulator of iron metabolism 19PubMed Central. Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
This pathway is clinically important because in conditions like thalassemia, where the bone marrow is extremely active but producing defective red blood cells, erythroferrone is chronically elevated. That keeps hepcidin suppressed and drives excessive iron absorption on top of whatever iron is coming in through transfusions. Understanding this signal has opened the door to therapies that could target erythroferrone or its downstream effects to slow iron loading in these patients.
Iron and Infection
The body’s habit of locking iron away during inflammation is not just a side effect of the immune response. It is an active defense strategy. Many disease-causing bacteria need iron to grow, and vertebrates have evolved elaborate systems to restrict microbial access to this nutrient, a concept researchers call nutritional immunity.20PubMed Central. Nutritional immunity: the battle for nutrient metals at the host-pathogen interface By raising hepcidin and pulling iron out of circulation during infection, the body essentially starves invading microbes of a resource they need.
This creates a clinical tension. People with iron overload, whether from hemochromatosis or heavy transfusion, have more circulating iron available and may be more vulnerable to certain infections. Conversely, aggressively supplementing iron in people who are fighting an active infection can theoretically feed the pathogen. In malaria-endemic regions, for instance, clinical trials of blanket iron supplementation in children have sometimes produced mixed results, with concerns that iron availability could worsen malaria outcomes in some settings. The general principle is straightforward: the timing and context of iron supplementation matter, and giving iron during acute infection requires careful clinical judgment.
How Iron Disorders Are Diagnosed
Standard blood tests for iron status include serum ferritin, transferrin saturation, and a complete blood count. Ferritin gives a rough estimate of stored iron, while transferrin saturation indicates how much of the iron transport protein in your blood is actually carrying iron. These tests are cheap, widely available, and a reasonable starting point. But they have real limitations. Ferritin is also an inflammation marker, so it can be misleadingly elevated in someone who is inflamed but not iron-overloaded. Transferrin saturation fluctuates throughout the day and with meals.
For more precise measurement of organ iron, MRI has become the reference standard. MRI can detect and quantify iron deposits in the liver, heart, and other organs without a biopsy. The signal from iron-loaded tissue drops in a predictable way that correlates with the actual amount of iron present.21PubMed. MRI for the measurement of liver iron content, and for the diagnosis and follow-up of iron overload disorders Cardiac MRI is particularly valuable in transfusion-dependent patients because it can identify heart iron loading before symptoms appear, allowing chelation therapy to be intensified early enough to prevent irreversible damage.
For the inherited conditions like NBIA and sideroblastic anemias, genetic testing has increasingly replaced invasive procedures as the definitive diagnostic step. A targeted gene panel or whole-exome sequencing can pinpoint the responsible mutation and guide treatment decisions.
Treatment Options
For hereditary hemochromatosis, the oldest and simplest treatment remains phlebotomy: regularly drawing blood to force the body to use up its excess iron building new red blood cells. It is safe, effective, and often the only treatment needed. Patients typically undergo weekly or biweekly phlebotomy until ferritin levels normalize, then switch to maintenance sessions several times a year.22Journal of Trace Elements in Medicine and Biology. Iron mobilization using chelation and phlebotomy
For transfusional iron overload, chelation therapy is the mainstay. Three chelating agents are available, each with different dosing routes and side-effect profiles. The choice depends on the patient’s tolerance, organ involvement, and practical considerations around adherence. Some patients need a combination of agents to keep iron levels under control.
Researchers are also developing therapies that target the hepcidin pathway directly. For conditions where hepcidin is inappropriately high, such as anemia of inflammation, experimental approaches include antibodies that bind and neutralize hepcidin, inhibitors of the signaling pathways that stimulate hepcidin production, and molecules that stabilize ferroportin against hepcidin-induced breakdown.23PubMed Central. Hepcidin antagonists for potential treatments of disorders with hepcidin excess None of these have reached routine clinical use yet, but they represent a shift from treating symptoms to correcting the underlying regulatory defect.
Iron, the Gut, and Unintended Consequences of Supplementation
Iron supplements are among the most commonly prescribed treatments worldwide, but they come with an underappreciated side effect. Most oral iron is poorly absorbed, meaning that most of the dose passes through the stomach and into the colon, where it becomes available to gut bacteria. Excess iron in the gut can shift the composition of the microbial community, potentially favoring less beneficial species.24PubMed Central. Iron Supplementation Influence on the Gut Microbiota and Probiotic Intake Effect in Iron Deficiency – A Literature-Based Review This may partly explain the gastrointestinal side effects, including nausea, constipation, and dark stools, that cause many people to abandon their iron supplements before completing a course.
The clinical takeaway is that iron supplementation should be targeted rather than blanket. For straightforward dietary iron deficiency, oral supplements work well despite the gut symptoms. For anemia of inflammation, oral iron is often ineffective and intravenous iron or treatment of the underlying cause may be more appropriate. And in populations where infection risk is high, untargeted mass supplementation programs need to weigh the benefits of correcting deficiency against the potential for fueling pathogens and disrupting the gut ecosystem.
Pregnancy and Placental Iron Transfer
Pregnancy dramatically increases iron demand. The growing fetus, the expanding maternal blood volume, and the placenta itself all consume iron at rates far above non-pregnant baseline. The placenta actively transports iron from mother to fetus and has its own set of iron-handling proteins that respond to both maternal and fetal signals.25PubMed Central. Placental iron transport: The mechanism and regulatory circuits Disruptions in this transfer can lead to adverse outcomes for both mother and baby, including low birth weight and preterm delivery.
Maternal hepcidin levels normally fall during pregnancy to allow greater iron absorption, but women who enter pregnancy with pre-existing inflammatory conditions or who develop gestational complications may not suppress hepcidin adequately. Their fetuses can end up iron-deprived even when the mother’s total body iron looks sufficient on paper. Monitoring iron status during pregnancy and tailoring supplementation to actual need, rather than relying on one-size-fits-all prenatal vitamin doses, is an evolving area of clinical practice that reflects the broader lesson of iron metabolism disorders: context determines whether iron is friend or foe.